What is the difference between Apolipoprotein B (Apo B) and Lipoprotein(a) (Lp(a))?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Apo B vs Lp(a): What's the Difference?

Apo B is a structural protein found on the surface of all "bad" cholesterol particles (like LDL), while Lp(a) is a specific type of cholesterol particle that contains both Apo B plus an additional sticky protein called apolipoprotein(a) attached to it—making Lp(a) essentially a modified, more dangerous version of LDL. 1

The Basic Structure

Apo B (Apolipoprotein B):

  • Think of Apo B as a name tag that sits on the surface of cholesterol-carrying particles 1
  • Every single LDL particle (the "bad cholesterol") has exactly one Apo B molecule on it 1
  • Measuring Apo B tells you how many total "bad" cholesterol particles are floating in your blood 2
  • It's like counting the number of delivery trucks carrying cholesterol, rather than weighing the cargo 2

Lp(a) (Lipoprotein(a)):

  • Lp(a) is a complete cholesterol particle that looks like LDL but has an extra protein (apolipoprotein(a)) glued onto it with a chemical bond 3, 1
  • This extra protein makes Lp(a) stickier and more likely to get trapped in artery walls 4
  • The lipid core (the cholesterol inside) is virtually identical to regular LDL 1
  • Because Lp(a) contains one Apo B molecule, it gets counted when you measure total Apo B 5

Why This Matters for Your Heart

The danger level is dramatically different:

  • Lp(a) is approximately 6-7 times more dangerous than regular LDL particles on a per-particle basis 6, 7
  • Lp(a) accumulates in artery plaques more than twice as much as regular LDL does 4
  • Once Lp(a) gets into the artery wall, 83% of it becomes tightly bound and difficult to remove, compared to only 32% of regular LDL 4

Risk thresholds differ significantly:

  • Elevated Lp(a) is defined as levels >30 mg/dL or >75 nmol/L 3, 8
  • This affects 20-30% of the global population—over one billion people worldwide 3
  • Your Lp(a) level is determined by your genes and stays relatively stable throughout your life 8

How They Respond to Treatment

This is a critical difference:

Apo B (and regular LDL) responds well to standard treatments:

  • Statins effectively lower Apo B by increasing the liver's ability to clear these particles 1
  • PCSK9 inhibitors also reduce Apo B levels 1

Lp(a) is stubbornly resistant to most treatments:

  • Statins do NOT lower Lp(a) levels, even though they lower other Apo B particles 3, 1
  • This is because Lp(a) uses different clearance pathways involving multiple receptors (SR-BI, LRP1, plasminogen receptors) rather than just the LDL receptor 3, 1
  • Niacin reduces Lp(a) by 30-35% and is currently the most recommended medication specifically for Lp(a) reduction 8
  • Lipoprotein apheresis (a filtering procedure) can reduce Lp(a) by up to 80% 8

The Measurement Confusion

A common pitfall: When you get standard cholesterol testing, the "LDL cholesterol" number includes cholesterol from both regular LDL and Lp(a) particles 3, 1

  • Lp(a) is composed of 30-45% cholesterol by mass, and this gets counted as "LDL-C" 3
  • If you have high Lp(a), your reported LDL cholesterol may overestimate your true LDL and underestimate your actual risk 3
  • This is why measuring Apo B alone may considerably underestimate risk in people with elevated Lp(a) 6

Who Should Get Tested

Lp(a) measurement is recommended for: 3, 8

  • People with premature heart disease (before age 55 in men, 65 in women)
  • Family history of premature heart disease or elevated Lp(a)
  • Familial hypercholesterolemia
  • Recurrent cardiovascular events despite optimal cholesterol treatment
  • ≥5% 10-year risk of fatal cardiovascular disease

Important caveat: You generally only need to check Lp(a) once in your lifetime since it's genetically determined and doesn't change 8

The Bottom Line for Risk Assessment

In practical terms:

  • Apo B tells you the total number of all atherogenic particles (including Lp(a))
  • But if your Lp(a) is high, each of those Lp(a) particles carries about 6-7 times more risk than the other particles counted in your Apo B 6, 7
  • A novel metric called "risk-weighted Apo B" has been proposed: Risk-weighted ApoB = ApoB + (Lp(a) × 6) to account for this difference 6

References

Guideline

Cardiovascular Risk Assessment Using Apolipoprotein Profiles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lipoprotein(a) Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.